Latest News

QuantumScape Stock Soars 21% Following $7.5bn EV Charging Network Investment


American City Business Journals

Viatris keen to increase dividends

Canonsburg-based drug manufacturer Viatris Inc. said its initial return to shareholders in 2022 will come in the form of dividends, with CEO Michael Goettler not completely shutting the door on stock buybacks but saying the latter was a more complex issue. Viatris (NYSE: VTRS), which will turn a year old next week, is the combination of Mylan NV and the Upjohn unit of Pfizer Inc. (NYSE: PFE). Viatris had earnings of $311.5 million, 26 cents a share, on revenue of $4.5 billion, compared to $185.7 million, 36 cents a share, on revenue of $2.9 million for Mylan and Upjohn a year ago.

Wall Street ‘permanently changed’ by meme stocks, retail trading: star YouTube trader

Previous article

Chipmaker AMD just scored a big deal with Meta

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News